InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
…
0,243€
0,41%
Echtzeit-Aktienkurs InMed Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur InMed Pharmaceuticals Inc. Aktie
InMed Pharmaceuticals gets extended Nasdaq compliance period By Investing.com
InMed Pharmaceuticals gets extended Nasdaq compliance period…
InMed Pharmaceuticals gets 180-Day extension to regain compliance with Nasdaq
…